NOVEN PHARMACEUTICALS INC.

In News

Manufacturing firm seeks Miami-Dade incentives for expansion - The Business Journals

The Business Journals - Mar 13, 2024

Noven Debuts Optional Companion App for Patients with ADHD – Mindful Patch – at APSARD 2025 - Business Wire

Business Wire - Jan 14, 2025

NOVEN TO PARTICIPATE IN ANNUAL INTERNATIONAL CONFERENCE ON ADHD (CHADD) - PR Newswire

PR Newswire - Nov 10, 2022

Noven resolves FDA warning for Miami facility - BioPharma Dive

BioPharma Dive - Apr 26, 2018

Japanese drugmaker Noven gets county aid to expand here - Miami Today

Miami Today - Mar 26, 2024

Noven Pharmaceuticals, Inc. - MultiVu

MultiVu - Nov 05, 2013

Noven Pharmaceuticals Inc. Release: New Minivelle (Estradiol Transdermal System) 0.025 mg/day Dose Now Available by Prescription in U.S. Pharmacies - BioSpace

BioSpace - Feb 12, 2015

Asenapine Approved as First Transdermal Patch for Treatment of Schizophrenia - Pharmacy Times

Pharmacy Times - Oct 15, 2019

A Transdermal System for the Treatment of Schizophrenia - Psychiatric Times

Psychiatric Times - Dec 15, 2020

Pharmaceutical company could expand Miami-Dade County campus - The Business Journals

The Business Journals - Aug 24, 2023

Noven to Acquire JDS Pharma - Contract Pharma

Contract Pharma - Jul 10, 2007

FDA Approves First Non-Hormonal Treatment for Menopausal Hot Flashes - HCPLive

HCPLive - Aug 27, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment